The 20 Best Glycogen Storage Disease Type 5 Doctors in The United States

Salman Bhai, M.D., is an Assistant Professor in the Department of Neurology at UT Southwestern Medical Center and the Director of the Neuromuscular Center in the Institute of Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas. He specializes in neuromuscular disorders, particularly muscle disorders.Dr. Bhai earned his medical degree at Harvard University. He completed a residency in neurology at Brigham and Women's Hospital and Massachusetts General Hospital, where he also received advanced training through a fellowship in neuromuscular medicine and earned a medical education certificate.Certified by the American Board of Psychiatry and Neurology and the American Board of Electrodiagnostic Medicine, he joined the UT Southwestern faculty in 2021. He is a member of the American Academy of Neurology, the American Academy of Neuromuscular & Electrodiagnostic Medicine, the Dallas County Medical Society, and the Texas Neurological Society.Dr. Bhai's clinical interests include the evaluation, diagnosis, and treatment of neuromuscular disorders. He focuses on patients with inflammatory and metabolic myopathies as well as those with immune checkpoint inhibitor complications.Dr. Bhai's research focuses on understanding how muscles communicate with other organ systems, particularly when muscle is inflamed, such as in myositis. The goal of his research is to better understand, diagnose, and treat patients with myositis through exercise and muscle physiology studies as well as through clinical trials. Among other work, he serves as the Principal Investigator for four clinical trials related to inflammatory and metabolic myopathies. Dr. Bhai is rated as a Distinguished provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Glycogen Storage Disease Type 5, Inclusion Body Myositis, Dermatomyositis, Polymyositis, and Shoulder Arthroscopy.

Dr. Leung obtained her undergraduate degree in biochemical sciences from Harvard University. While attending medical school at Duke University, she completed a year-long research fellowship studying genetic markers of late-onset Alzheimer’s disease at the National Institute on Aging as part of the NIH Clinical Research Training Program. She completed her neurology residency and clinical neurophysiology fellowship at Stanford University Medical Center, and is currently a Ph.D. candidate in the graduate training program in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Leung joined the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute as a translational research fellow in 2010 and was appointed to the faculty in 2014. Her clinic specializes in electromyography and the diagnosis and treatment of hereditary muscle diseases. Dr. Leung’s research focuses on the development of imaging biomarkers and outcome measures for muscle diseases. She is the principal investigator for a longitudinal cohort study of whole-body MRI in facioscapulohumeral muscular dystrophy. Dr. Leung is also a site principal investigator for the Ionis-DMPKRx trial, a phase Ib/IIa clinical trial of a novel RNA-based therapy for myotonic muscular dystrophy. Dr. Leung is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, and Dysferlinopathy.

Vern Juel is a Neurologist in Durham, North Carolina. Dr. Juel has been practicing medicine for over 37 years and is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Myasthenia Gravis, Lambert-Eaton Syndrome, Inclusion Body Myositis, Meige Syndrome, and Thymectomy.

Aiesha Ahmed is a Neurologist in Grand Rapids, Michigan. Dr. Ahmed has been practicing medicine for over 26 years and is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Myasthenia Gravis, Glycogen Storage Disease Type 5, Myotonic Dystrophy Type 2, and Myotonic Dystrophy.

Ronald Haller is an Internal Medicine provider in Dallas, Texas. Dr. Haller is rated as a Distinguished provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Glycogen Storage Disease Type 5, Myoglobinuria Recurrent, Limb-Girdle Muscular Dystrophy Type 2A, and Phosphoglycerate Kinase Deficiency.

Richard Wilcon is a primary care provider, practicing in Internal Medicine in Plainfield, Connecticut. Dr. Wilcon is rated as a Distinguished provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Glycogen Storage Disease Type 5, Atherosclerosis, Coronary Heart Disease, and Venous Thromboembolism (VTE).

Stephen Ryan is a Neurologist in Lexington, Kentucky. Dr. Ryan is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Generalized Tonic-Clonic Seizure, Myasthenia Gravis, Seizures, and Glycogen Storage Disease Type 5.

Margherita Milone is a Neurologist in Rochester, Minnesota. Dr. Milone is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Necrotizing Myopathy (NM), Progressive External Ophthalmoplegia, Nemaline Myopathy, and Tubular Aggregate Myopathy.

Benjamin Claytor is a Neuromusculoskeletal Medicine provider in Cleveland, Ohio. Dr. Claytor is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Myasthenia Gravis, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Miller-Fisher Syndrome.

Robert Marquardt is a Neurologist in Cleveland, Ohio. Dr. Marquardt has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Cramp-Fasciculation Syndrome, Foot Drop, Hereditary Sensory and Autonomic Neuropathy Type 2, Congenital Insensitivity to Pain with Anhidrosis, and Thrombectomy.

Brittani Moeller is a primary care provider, practicing in Family Medicine in Kearney, Nebraska. Dr. Moeller is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Myotonia Congenita, Low Potassium Level, Gitelman Syndrome, and Type 2 Diabetes (T2D). Dr. Moeller is currently accepting new patients.

Amro Stino, MD is an Associate Professor in the Department of Neurology in the University of Michigan Medical School, Division of Neuromuscular Medicine. Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired peripheral neuropathy.A native of Ann Arbor, MI and a product of Ann Arbor schools, Dr. Stino went on to pursue a Bachelor of Science degree in Brain, Behavioral, and Cognitive Sciences from the University of Michigan, Ann Arbor, which he completed in 2006. He received his medical degree from Wayne State University, School of Medicine in Detroit, MI in 2010 and completed a transitional year internship at St. Joseph Mercy Hospital, in Ann Arbor, MI. He then completed his neurology residency training at the Wayne State University, School of Medicine – Detroit Medical Center, followed by a fellowship in clinical neurophysiology / neuromuscular medicine at The Mayo Clinic in Arizona. He joined The Ohio State University faculty in 2015 as Director of the Peripheral Neuropathy Clinic and Autonomic Lab. During his time there, he oversaw expansion of diagnostic testing and clinical operations of both, helping provide more comprehensive neuropathy care for central and southern Ohio patients seeking multi-disciplinary acquired neuropathy care. He helped obtain CIDP and CMT center of excellence accreditation. He joined the University of Michigan faculty in 2019 as Director of the Peripheral Neuropathy clinic and Co-director of the Autonomic Lab. Currently, he serves as site principal investigator on multi-center studies in the realms of metabolic and autoimmune neuropathy. He is presently conducting an investigator initiated phase 1b trial on the novel use of Lenalidomide in anti-MAG neuropathy.Dr. Stino is an advocate for patient awareness and education in autoimmune neuropathy and serves as physician liaison for the GBS-CIDP foundation, with whom he was interviewed on Good Day Columbus as part of GBS-CIDP awareness month. He also takes great interest in helping patients tackle peripheral neuropathy care in an evidence based fashion, particularly as it pertains to pain control.Dr. Stino enjoys working alongside and mentoring neuromuscular fellows, neurology residents, and medical students who rotate with him in clinic or inpatient service. He serves on the Peripheral Nerve Society Junior Board, which helps organize an annual educational course for attendees. His online videos on autoimmune neuropathy, small fiber neuropathy, and postural tachycardia syndrome have been viewed by thousands.He remains a dedicated Wolverine, despite having worked down south. Dr. Stino is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Chronic Polyradiculoneuritis, and Familial Dysautonomia.

Rebecca Kuenzler is a Neuromusculoskeletal Medicine provider in Cleveland, Ohio. Dr. Kuenzler has been practicing medicine for over 32 years and is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy.

Kate Daniello is a Neuromusculoskeletal Medicine specialist and a Neurologist in Worcester, Massachusetts. Dr. Daniello has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Progressive External Ophthalmoplegia, Horizontal Gaze Palsy with Progressive Scoliosis, Glycogen Storage Disease Type 5, and Myasthenia Gravis.

Zach London, M.D. is a Professor in the University of Michigan Medical School. Dr. London grew up in Milwaukee, Wisconsin. He graduated Magna Cum Laude from Brown University in 1997. He attended medical school at the University of Wisconsin – Madison, graduating in 2001. He completed a Preliminary Medicine Internship at St. Joseph Mercy Hospital in Ann Arbor in 2001, followed by Neurology Residency at the University of Michigan. After graduation from residency, he did a one-year fellowship in Clinical Neurophysiology/EMG at the University of Michigan.He joined the University of Michigan faculty as a neuromuscular neurologist in 2006, and has served as Program Director of the neurology residency program. Dr. London’s scholarly focus is the development of interactive educational tools, with a focus on educational boardgames. He is the founder of Neurd Games, which includes popular titles such as The Lesion: Charcot’s Tournament, The Plexus, Endowed Chairs: Neurology, Formaina, and Field Cut. He also created EMG Whiz, a popular web-based EMG training simulator, and mobile applications to teach the tenets of neuroanatomic localization.He has published online learning modules for the American Academy of Neurology and other national organizations, in addition to traditional publishing research regarding medical education and electrodiagnostic studies.Dr. London has been recognized with numerous national teaching awards, including the American Academy of Neurology (AAN) A.B. Baker Lifetime Achievement Award in Neurologic Education in 2023, The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Innovation Award in 2021, and the American Neurological Association (ANA) Distinguished Teacher Award in 2017. At the University of Michigan, he received the 2013 Silver Shovel Award, the Provost’s Teaching Innovation Prize in 2015, and, in 2017, the Kaiser Permanente Award. Departmental honors include the Status Pedagogicus Award in 2008, and the James Albers Collegiate Professorship in 2018. He has been an honorary member of the GALENS medical society most years since 2011. Dr. London regularly speaks at national meetings on topics of medical education, game development, and clinical neurophysiology. He has served as chair or member of committees and workgroups for the AAN, ANA, AANEM, and ACGME, including serving as the Chair of the Consortium of Neurology Program Directors.Outside his work, Zach London is a founding board member of the Penny Seats Theatre Company in Ann Arbor. He has also composed and released one original song every month since 1993, posting them on his personal website www.hardtaco.org. Dr. London is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Polyradiculoneuritis.

Gerald Steinberg is a primary care provider, practicing in Internal Medicine in Springfield, Massachusetts. Dr. Steinberg has been practicing medicine for over 55 years and is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Dementia, Glycogen Storage Disease Type 5, Vascular Dementia, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Steinberg is currently accepting new patients.

Christopher Babiuch is a primary care provider, practicing in Family Medicine in Lorain, Ohio. Dr. Babiuch has been practicing medicine for over 25 years and is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D).

Long Loo is a Neurologist in Kansas City, Kansas. Dr. Loo has been practicing medicine for over 13 years and is rated as an Advanced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Miller-Fisher Syndrome, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Myasthenia Gravis. Dr. Loo is currently accepting new patients.

Jennifer Martinez is a Neurologist in Rochester, Minnesota. Dr. Martinez is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Primary Lateral Sclerosis, and Gastrostomy.

Colin Quinn is a Neurologist in Philadelphia, Pennsylvania. Dr. Quinn is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 5. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Inclusion Body Myositis, Progressive Hemifacial Atrophy, and Gastrostomy. Dr. Quinn is currently accepting new patients.